Preferential presentation of herpes simplex virus T-cell antigen by HLA DQA1*0501/DQB1*0201 in comparison to HLA DQA1 *0201/DQB1*0201

Human Immunology

Volumn 53, Issue 2, 1997, Pages 195-205

  Koelle, David M ^a,c   Johnson, Matthew L ^a   Ekstrom, Aimee N ^a   Byers, Patricia ^b   Kwok, William W ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HLA DQ ANTIGEN; T LYMPHOCYTE ANTIGEN;

ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; CYTOTOXICITY; DNA POLYMORPHISM; EPSTEIN BARR VIRUS; GENE LOCUS; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 2; HOST RESISTANCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0030985014     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(97)00034-7     Document Type: Article

References (40)

1. Nepom GT: Class II antigens and disease susceptibility. Annu Rev Med 46:17, 1995.
2. Sollid LM, Markussen J, Ek H, Gjerde H, Vartdal F, Thorsby E: Evidence for a primary association of celiac disease to a particular DQ α/β heterodimer. J Exp Med 169:345, 1989.
3. Nepom GT, Erlich H: MHC class II molecules and autoimmunity. Annu Rev Immunol. 9:493, 1991.
4. Dayan CM, Londei M, Corcoran AE, GrubeckLoebenstein B, James RF, Rapoport B, Feldmann M: Autoantigen recognition by thyroid-infiltrating T cells in Graves disease. Proc Natl Acad Sci USA 88:7415, 1991.
5. Kimura S, Kotani T, McBride OW, Umeki K, Hirai JM, Nakayama T, Ohtaki S: Human thyroid peroxidase: complete cDNA and protein sequence, chromosome mapping, and identification of two alternatively spliced mRNAs. Proc Natl Acad Sci USA 84:5555, 1987.
6. Kwok WW, Nepom GT, Raymond FC: HLA-DQ polymorphisms are highly selective for peptide binding interactions. J Immunol 155:2468, 1995.
7. Marsh SGE, Bodmer JG: HLA class II nucleotide sequences, 1992. Immunogenetics 37:79, 1993.
8. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC: Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33, 1993.
9. Koelle DM, Abbo H, Peck A, Ziegweid K, Corey L: Direct recovery of HSV-specific T lymphocyte clones from human recurrent HSV-2 lesions. J Infect Dis 169:956, 1994.
10. Koelle DM, Corey L, Burke RL, Eisenberg RJ, Cohen GH, Pichyangkura R, Triezenberg SJ: Antigenic specificity of human CD4+ T cell clones recovered from recurrent genital HSV-2 lesions. J Virol 68:2803, 1994.
11. Yasukawa M, Yakushijin Y, Hasegawa H, Miyake M, Hitsumoto Y, Kimura S, Takechi N, Fujita S: Expression of perforin and membrane-bound lymphotoxin (tumor necrosis factor-B) in virus-specific CD4 + human cytotoxic T cell clones. Blood 81:1527, 1993.
12. Yasukawa M, Inatsuki A, Horiuchi T, Kobayashi Y: Functional heterogeneity among herpes simplex virusspecific human CD4+ T cells. J Immunol 146:1341, 1991.
13. Cunningham AL, Merigan TC: Leu-3 + T cells produce gamma-interferon in patients with recurrent herpes labialis. J. Immunol. 132:197, 1984.
14. Cunningham AL, Turner RR, Miller AC, Para MF, Merigan TC: Evolution of recurrent herpes simplex lesions: an immunohistologic study. J Clin Invest 75:226, 1985.
15. Cunningham AL, Nelson PA, Fathman CG, Merigan TC. Interferon gamma production by herpes simplex virus antigen-specific T cell clones from patients with recurrent herpes labialis. J Gen Virol 66:249, 1985.
16. Schmid DS, Rouse BT: The role of T cell immunity in control of herpes simplex virus. Curr Top Microbiol Immunol 179:57, 1992.
17. Kwok WW, Thurtle P, Nepom GT: A genetically controlled pairing anomaly between HLA-DQ alpha and DQ beta chains. J Immunol 143:3598, 1989.
18. Kimura A, Dong RP, Harada H, Sasazuki T: DNA typing of HLA class II genes in B-lymphoblastoid cell lines homozygous for HLA. Tissue Antigens. 40:5, 1992.
19. Hume CR, Shookster LA, Collins N, O'Reilly R, Lee JS: Bare lymphocyte syndrome: altered HLA class II expression in B cell lines derived from two patients. Hum Immunol 25:1, 1989.
20. Kieff ED, Hoyer B, Bachenheimer SL, Roizman B: Genetic relatedness of type 1 and type 2 herpes simplex viruses. J Virol 9:738, 1972.
21. Munemitsu S, Innis MA, Clark R, McCormick F, Ullrich A, Polakis P: Molecular cloning and expression of a G25K cDNA, the human homolog of the yeast cell cycle gene CDC42. Mol Cell Biol 10:5977, 1990.
22. Kitts PA, Ayres MD, Possee RD: Linearization of baculovirus DNA enhances the recovery of recombinant virus expression vectors. Nucleic Acids Res 18:5667, 1990.
23. Smith GE, Summers MD, Fraser MJ: Production of human beta-interferon in insect cells infected with a baculovirus expression vector. Mol Cell Biol 3:2156, 1983.
24. Kwok W, Koelle DM, Nepom GT: Interactions of peptide side chains with structurally complementary pockets in DQ molecules are critical for allele-specific peptide binding and T cell reactivity. Hum Immunol. 47:17, 1996.
25. Roizman B, Sears AE: Herpes simplex viruses and their replication. In The Human Herpesviruses. B. Roizman, R. J. Whitley, and C. Lopez, eds. Raven Press, Ltd, New York, 1993, p. 11.
26. Kwok WW, Domeier ME, Johnson ML, Nepom GT, Koelle DM: HLA-DQB codon 57 is a critical determinant of peptide binding and recognition. J Exp Med 183:1253, 1996.
27. Doherty DG, Koelle DM, Kwok WW, Masewicz S, Domeier ME, Nepom GT: Allelic variants of MHC class II molecules can act as partial agonists of antigen specific T cell responses. Hum Immunol 47:149, 1996.
28. Ashley R, Koelle DM: Immune responses to genital herpes infections. In Advances in Host Defense Mechanisms: Sexually Transmitted Diseases, vol. 8. T.C. Quinn, ed. Raven Press, New York, 1992, p. 201.
29. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC: Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215, 1994.
30. Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC: Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. Proc Natl Acad Sci USA 93:734, 1996.
31. Ghosh P, Amaya M, Mellins E, Wiley DC: The structure of an intermediate in class II maturation: CLIP bound to HLA-DR3. Nature 378:457, 1995.
32. Johansen BH, Vartdal F, Eriksen JA, Thorsby E, Sollid LM: Identification of a putative motif for binding to peptides to HLA-DQ2. Int Immunol 8:177, 1996.
33. Johansen BH, Buus S, Vartdal F, Viken H, Eriksen JA, Thorsby E, Sollid LM: Binding of peptides to HLA-DQ molecules: peptide binding properties of the disease associated HLA-DQ(α 1*0501, βl*0201) molecule. Intl Immunol 6:453, 1994.
34. Gjertsen HA, Lundin KEA, Sollid LM, Eriksen JA, Thorsby E: T cells recognize a peptide derived from alphagliadin presented by the celiac disease-associated HLA-DQ (alpha l*0501, beta l*0201) heterodimer. Hum Immunol 39:243, 1994.
35. Verreck FA, van de Poel A, Termijtelen A, Amons R, Drijfhout JW, Koning F: Identification of an HLA-DQ2 peptide binding motif and HLA-DPw3-bound self-peptide by pool sequencing. Eur J Immunol 24:375, 1994.
36. Rammensee H-G, Friede T, Stevanovic S: MHC ligands and peptide motifs: first listing. Immunogenetics 41:178, 1995.
37. Serra HM, Crimi C, Sette A, Celis E: Fine restriction analysis and inhibition of antigen recognition in HLADQ-restricted T cells by major histocompatibility complex blockers and T cell receptor antagonists. Eur J Immunol 23:2967, 1993.
38. Lambert LE, Unanue ER: Analysis of the interaction of peptide hen egg lysozyme (34-45) with the I-Ak molecule. J Immunol 143:802, 1989.
39. Geluk A, van Meijgaarden KE, Janson AAM, Drijfhout JW, Meloen RH, de Vries RRP, Ottenhoff THM: Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motifs and enables the design of allele-specific competitor peptides. J Immunol 149:2864, 1992.
40. McNicholl JM, Whitworth WC, Oftung F, Fu X, Shinnick T, Jensen PE, Simon M, Wohlhueter RM, Karr RW: Structural requirements of peptide and MHC for DR(alpha, beta l*0401) - restricted T cell antigen presentation. J Immunol 155:1951, 1995.